claim
Clinical trials employing mesenchymal stem cells to treat chronic kidney disease face challenges including determining the optimal administration method, ensuring cell flourishing, tracking injected cells, preventing immunological rejection, improving homing and engraftment, and increasing immune acceptance.

Authors

Sources

Referenced by nodes (2)